Overview

Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and feasibility of a novel oxygen carrying solution, HBOC-201, in the setting of PCI for Acute Coronary Syndromes from randomization til hospital discharge.
Phase:
Phase 2
Details
Lead Sponsor:
Biopure Corporation
Treatments:
HBOC 201